Spain, Jan. 7 -- Spain based LILLY, S.A. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products - Supply of Ixekizumab (DOE) and Baricitinib (DOE). The value of the contract is worth 1311610320 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....